As inferred from our results, CD8+ NTeff are less influenced by tumor-derived inhibitory factor TGF-β, i.e., effectors derived from naïve cells are less affected by tumor suppression mechanisms driven by Foxp1 in response to TGF-β. The gene discussed is TGFB1; the disease is neoplasm.